CelVida

Celvida is a clinical-stage biotechnology company based in Brazil that specializes in the development of advanced regenerative medicine and stem cell therapies. The company focuses on utilizing mesenchymal stem cells to treat a variety of chronic and debilitating conditions, including cardiovascular diseases, neurological disorders, and orthopedic injuries. Celvida operates a state-of-the-art laboratory facility that adheres to Good Manufacturing Practices (GMP) for the processing and expansion of cellular products. Their pipeline includes several programs in Phase 1 and Phase 2 clinical trials, positioning them as a leader in the South American regenerative medicine landscape. By leveraging both autologous and allogeneic approaches, Celvida aims to provide innovative solutions for patients with limited treatment options.